Houlihan Lokey (NYSE:HLI) Releases Earnings Results

Houlihan Lokey (NYSE:HLI) announced its earnings results on Wednesday. The financial services provider reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.15, Briefing.com reports. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The company had revenue of $574.96 million during the quarter, compared to the consensus estimate of $537.93 million. During the same period in the previous year, the firm posted $1.11 earnings per share. The company’s revenue was up 23.1% on a year-over-year basis.

Houlihan Lokey Trading Down 1.2 %

Shares of HLI stock traded down $2.02 during trading hours on Wednesday, hitting $164.68. 542,718 shares of the company were exchanged, compared to its average volume of 320,049. The business has a 50 day moving average of $160.25 and a two-hundred day moving average of $145.03. Houlihan Lokey has a 52 week low of $99.35 and a 52 week high of $175.21. The company has a market capitalization of $11.29 billion, a PE ratio of 40.07 and a beta of 0.66.

Analysts Set New Price Targets

Several equities analysts recently weighed in on HLI shares. UBS Group increased their price objective on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. cut their price objective on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a report on Wednesday, July 31st. Morgan Stanley increased their price objective on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a report on Monday, September 23rd. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $154.00 price objective (up from $139.00) on shares of Houlihan Lokey in a report on Wednesday, July 31st. Finally, Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research note on Thursday, September 12th. They issued an “underweight” rating and a $149.00 target price for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $157.00.

Insider Transactions at Houlihan Lokey

In other news, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total transaction of $30,498.00. Following the completion of the sale, the director now owns 7,001 shares of the company’s stock, valued at $1,067,582.49. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, General Counsel Christopher M. Crain sold 1,000 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $152.49, for a total transaction of $30,498.00. Following the transaction, the director now owns 7,001 shares of the company’s stock, valued at $1,067,582.49. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 9,917 shares of company stock valued at $1,513,129 over the last quarter. Corporate insiders own 25.97% of the company’s stock.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.